COVID-19 and myocardial injury: Targeting elevated biomarkers for potential novel therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19 and myocardial injury: Targeting elevated biomarkers for potential novel therapies

Published:2024-01 Issue: Volume:79 Page:100473
ISSN:1807-5932
Container-title:Clinics
language:en
Short-container-title:Clinics

Author:

Li Pengyang^ORCID,Chen Qun^ORCID,Jovin Ion S.^ORCID,Mankad Anit,Huizar Jose F.^ORCID,Markley John D.^ORCID,Bart Bradley^ORCID,Hattler Brack^ORCID,Lesnefsky Edward^ORCID,McFalls Edward O.^ORCID

Publisher

Elsevier BV

Reference52 articles.

1. Cardiac troponins: from myocardial infarction to chronic disease;Park;Cardiovasc Res,2017

2. 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group;Schiele;Eur Heart J Acute Cardiovasc Care,2021

3. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

4. Cardiac troponins: 25 years on the stage and still improving their clinical value;Alquézar-Arbé;Crit Rev Clin Lab Sci,2017

5. Interpreting troponin elevations: do we need multiple diagnoses?;Pierpont;Eur Heart J,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3